詳細検索
2024/09/12 10:27 143.85 円 158.71 円 190.22 円 米国女性健康検査市場:遺伝性癌(子宮頸癌、卵巣癌、乳癌)別、生殖健康と感染症(CT/NG検査、着床前遺伝学的検査(PGT)、単純ヘルペスウイルス(HSV)、肝炎、性感染症、膣感染症、PAPスメア検査、HIV検査、妊娠・排卵検査、HPV検査)、出生前スクリーニングおよび診断検査(非侵襲的出生前検査(NIPT)、母体血清スクリーニング(MSS)、出生前診断検査)、地域別、競争予測と機会、2018年-2028年United States Women Health Laboratory Testing Market By Hereditary Cancer (Cervical Cancer, Ovarian Cancer, Breast Cancer), By Reproductive Health and Infectious Diseases (CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing), By Prenatal Screening and Diagnostic Testing (Non-Invasive Prenatal Testing (NIPT), Maternal Serum Screening (MSS), Prenatal Diagnostic Testing), By Region, Competition Forecast & Opportunities, 2018-2028出版社:TechSci Research ![]()
ご購入・見積もりのご依頼、その他お問合せはデータリソースまでお気軽にどうぞ |